ISRCTN14254122
Completed
Phase 4
Pain relief with disease modification by Capsaicin 8% patch: a clinical study in diabetic peripheral neuropathy.
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Diabetic peripheral neuropathy
- Sponsor
- Imperial College London
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
2022 Results article in https://doi.org/10.3389/fneur.2022.998904 (added 11/10/2023)
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Painful distal, symmetrical, sensorimotor polyneuropathy due to diabetes of at least 1 year duration
- •2\. Average daily pain score of \=4/10 for painful diabetic neuropathy
Exclusion Criteria
- •1\. Other painful medical conditions
- •2\. Significant renal impairment
- •3\. Heart failure
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Treatment of nerve pain in patients with diabetes with a capsaicin (chilli pepper) patch (skin plaster).EUCTR2017-004746-17-GBJoint Research Compliance Office, Imperial College London and Imperial College Healthcare NHS Trust50
Recruiting
Early Phase 1
Exploring the Benefit of Topical Capsaicin in Treating Pain From Chemo-induced Peripheral Neuropathy: a Longitudinal Single Center Pilot StudyPeripheral Neuropathy Due to ChemotherapyNCT06744816M.D. Anderson Cancer Center20
Completed
Phase 3
Topical capsaicin in burning mouth syndromeburning mouth syndromeOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonACTRN12608000235303Sao Paulo University20
Completed
Not Applicable
ClUDo: The Clinical Utility of Capsaicin Dose Response Curves to Discriminate Cough Hyper-responsivenessChronic coughRespiratoryISRCTN23684347niversity Hospital of South Manchester NHS Foundation Trust (UK)200
Completed
Phase 3
The role of topical capsaicin gel in pain management during microfocused ultrasound treatment for neck laxityneck skin laxityAnesthesia, Chili, Lidocaine, Nociceptive pain, Prilocaine, TRPV1 receptorTCTR20220225006Division of Dermatology, Department of medicine, Faculty of Medicine, Ramathibodi hospital24